Published in J Neurol Sci on January 01, 1994
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies. J Exp Med (2013) 1.88
Biological markers of amyloid beta-related mechanisms in Alzheimer's disease. Exp Neurol (2009) 1.47
Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc Natl Acad Sci U S A (2001) 1.19
IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis. J Neuroinflammation (2012) 0.89
A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke (2001) 5.81
APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology (1999) 4.37
Tissue receptor for cholera exotoxin: postulated structure from studies with GM1 ganglioside and related glycolipids. Infect Immun (1973) 4.08
Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol (1999) 3.62
The state and fate of Himalayan glaciers. Science (2012) 3.33
Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol (1995) 3.23
Development of the EURO-D scale--a European, Union initiative to compare symptoms of depression in 14 European centres. Br J Psychiatry (1999) 3.13
Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release (2000) 3.07
A 24-year follow-up of body mass index and cerebral atrophy. Neurology (2004) 2.91
Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease. Arch Neurol (2000) 2.66
A procedure for the quantitative isolation of brain gangliosides. Biochim Biophys Acta (1980) 2.63
Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl (2000) 2.56
Burden of illness and suicide in elderly people: case-control study. BMJ (2002) 2.51
Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology (2008) 2.41
A 40-year follow-up of patients with obsessive-compulsive disorder [see commetns]. Arch Gen Psychiatry (1999) 2.31
Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis. Neurology (2010) 2.26
Onset of terminal decline in cognitive abilities in individuals without dementia. Neurology (2008) 2.24
Interaction of cholera toxin and membrane GM1 ganglioside of small intestine. Proc Natl Acad Sci U S A (1975) 2.18
CD62/P-selectin recognition of myeloid and tumor cell sulfatides. Cell (1991) 2.16
Real-time elastography--an advanced method of ultrasound: First results in 108 patients with breast lesions. Ultrasound Obstet Gynecol (2006) 2.12
Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin. Infect Immun (1982) 2.08
High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology (2005) 2.07
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry (1994) 1.98
Prevalence of depression and its treatment in an elderly population: the Cache County study. Arch Gen Psychiatry (2000) 1.97
Krabbe disease: a galactosylsphingosine (psychosine) lipidosis. J Lipid Res (1980) 1.93
Fixation and inactivation of cholera toxin by GM1 ganglioside. Scand J Infect Dis (1973) 1.90
Receptor-specific large-scale purification of cholera toxin on silica beads derivatized with lysoGM1 ganglioside. Eur J Biochem (1981) 1.89
Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem (2001) 1.87
Incidence of ROP in two consecutive Swedish population based studies. Br J Ophthalmol (2002) 1.86
Depressive symptoms and risk of stroke: the Rotterdam Study. J Neurol Neurosurg Psychiatry (2008) 1.84
Distribution and fatty acid composition of phosphoglycerides in normal human brain. J Lipid Res (1968) 1.83
White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors. Acta Neurol Scand (1991) 1.77
Depression symptoms in late life assessed using the EURO-D scale. Effect of age, gender and marital status in 14 European centres. Br J Psychiatry (1999) 1.75
Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma. Amyloid (2000) 1.75
CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology (2005) 1.73
Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease. J Neurochem (1982) 1.72
Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry (1979) 1.71
Treatment of psoriasis with bromocriptin. Arch Dermatol Res (1981) 1.70
Celiac disease, brain atrophy, and dementia. Neurology (1991) 1.69
Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol (1999) 1.68
CCR5 genotype and resistance to vertical transmission of HIV-1. J Acquir Immune Defic Syndr (1999) 1.67
Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides. Int Arch Allergy Appl Immunol (1983) 1.67
The 32-year relationship between cholesterol and dementia from midlife to late life. Neurology (2010) 1.64
Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study. Eur J Neurol (2009) 1.64
Ultrastructural localization of cell membrane GM1 ganglioside by cholera toxin. Proc Natl Acad Sci U S A (1977) 1.61
Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet (2008) 1.59
Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke (1995) 1.58
Altered protein tyrosine phosphorylation in asthmatic bronchial epithelium. Eur Respir J (2005) 1.56
Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol (1997) 1.51
A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia. Neurology (1998) 1.50
Little evidence for different phenomenology in poststroke depression. Acta Psychiatr Scand (2010) 1.50
A population-based study on the incidence of dementia disorders between 85 and 88 years of age. J Am Geriatr Soc (1996) 1.49
The role of amyloid beta-protein in Alzheimer's disease. Lancet (1992) 1.49
White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease. Neurology (2004) 1.47
Body mass index and white matter lesions in elderly women. An 18-year longitudinal study. Int Psychogeriatr (2004) 1.46
Specific gangliosides function as host cell receptors for Sendai virus. Proc Natl Acad Sci U S A (1981) 1.45
White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology (2010) 1.44
Dementia diagnoses from clinical and neuropsychological data compared: the Cache County study. Neurology (2000) 1.44
Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord. Biochim Biophys Acta (1994) 1.44
Altered blood-brain-barrier function in Alzheimer's disease? Acta Neurol Scand (1994) 1.44
Absence of hexosaminidase A and B in a normal adult. N Engl J Med (1975) 1.43
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI. Neurology (2007) 1.43
The prognosis and incidence of social phobia in an elderly population. A 5-year follow-up. Acta Psychiatr Scand (2010) 1.41
PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment. Dement Geriatr Cogn Disord (2008) 1.39
Increased expression of p38 MAPK in human bronchial epithelium after lipopolysaccharide exposure. Eur Respir J (2005) 1.39
Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J Neurochem (1994) 1.38
Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology (2006) 1.37
A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with "on-off" phenomena. Acta Neurol Scand (1987) 1.36
Normal pressure hydrocephalus. Predictive value of the cerebrospinal fluid tap-test. Acta Neurol Scand (1986) 1.35
Suicidal feelings in the last year of life in elderly people who commit suicide. Lancet (1999) 1.35
Human brain gangliosides: developmental changes from early fetal stage to advanced age. Biochim Biophys Acta (1989) 1.34
Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease. Am J Hum Genet (1983) 1.33
A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism. Clin Endocrinol (Oxf) (1988) 1.33
Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma. Br Med J (Clin Res Ed) (1984) 1.31
Treatment of psoriasis with somatostatin. Arch Dermatol Res (1982) 1.31
White matter changes and late-life depressive symptoms: longitudinal study. Br J Psychiatry (2007) 1.31
Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology (2012) 1.31
The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition. J Neurol Neurosurg Psychiatry (2005) 1.30
Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors. Acta Neurol Scand (1990) 1.29
Dementia: the leading predictor of death in a defined elderly population: the Cache County Study. Neurology (2004) 1.29
CT evaluation of coverage and congruency of the hip prior to osteotomy. Clin Orthop Relat Res (1988) 1.28
Deep frontal and periventricular age related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls: cross sectional results from the LADIS study. J Neurol Neurosurg Psychiatry (2009) 1.28
Sendai virus receptor: proposed recognition structure based on binding to plastic-adsorbed gangliosides. Proc Natl Acad Sci U S A (1980) 1.27
Adiposity indicators and dementia over 32 years in Sweden. Neurology (2009) 1.26
Sialosyllactotetraosylceramide, a novel ganglioside antigen detected in human carcinomas by a monoclonal antibody. FEBS Lett (1985) 1.26